Mallon: There does appear to be a trend toward elongated site activation timelines. It’s likely driven by increased protocol ...
Hosted on MSN
ICON suspends COVID vaccine study after BARDA notice
ICON plc (NASDAQ:ICLR) has announced the suspension of its COVID vaccine study following a stop work notice from BARDA. The company has ceased all screening and dosing activities for new participants ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback